B rain stimulation therapies have a long history, beginning with the development of electroconvulsive (also known as electroshock) therapy in the first half of the previous century, progressing with the development of other, more refined, methods to induce electrical currents in the living brain. Those methods are used to treat various psychiatric diseases, ranging from depression and bipolar disorder to posttraumatic stress disorder and schizophrenia. Obviously, a better understanding of the mechanism of action of these treatments will allow optimization of stimulation parameters to enhance and optimize the therapeutic effects. Such understanding would also be an important milestone in development of new versions of stimulation tools, to improve and adapt existing protocols individually to each patient, and to develop objective, quantifiable measures of therapeutic outcome. An appealing possibility to explain the effects of electricity-based therapies is their ability to change the brain network activity over time; that is, to enhance or suppress global neuronal activity or specifically to encourage the creation and strengthening of existing connections.
The 2 papers presented in this issue by Dr Zafiris J Daskalakis' group (see Voineskos et al 1 and Rajji et al 2 ) draw a comprehensive and consistent theory on the relation between schizophrenia, brain plasticity, and effectiveness of brain stimulation therapies. In this sense, schizophrenia is an interesting touchstone to examine the issue of brain stimulation plasticity-based treatments because it encompasses significant deficits in higher cognitive functions, including learning-related plastic changes. The first article 1 is a comprehensive review demonstrating neuroplastic impairments in schizophrenia as reflected in transcranial magnetic stimulation (TMS) studies that include measurements of neural excitability and inhibition levels by various paradigms of TMS. Dr Daskalakis and colleagues 1 nicely introduce the concept of brain plasticity impairments in schizophrenia, and suggest that cognitive deficits accompanying this disease, especially in executive attention and working memory, are caused by reduced ability of the brain to perform adaptation of its activity in response to experience and training. Patients with schizophrenia, compared with healthy subjects, do not show adaptation of their response to motor cortex magnetic stimulation following a motor training protocol. They do not show acquisition and strengthening of association between peripheral motor stimulation and motor responses induced by TMS in a paired associative stimulation (PAS) paradigm. In these studies, patients with schizophrenia, unlike healthy subjects, show no increase or decrease in activity as a result of repetitive stimulation of the motor cortex or adjacent areas. The authors 1 suggest alterations in glutamate (via N-methyl-d-aspartate receptors), gammaaminobutyric acid, and dopamine neurotransmission for explaining these neuroplastic impairments as these systems had been linked with long-term plasticity processes in basic electrophysiological studies and with morbidity of schizophrenia in neuropharmacological studies. The second article, by Dr Tarek K Rajji and colleagues, 2 describes current knowledge on various brain stimulation (TMS and direct electrical) approaches used in the treatment of schizophrenia. Search engines were scanned for relevant articles, and the results, concerning repetitive TMS, thetaburst stimulation, PAS, and transcranial direct current stimulation, are summarized comprehensively. Importantly, these therapeutic methods are reviewed in light of their ability to produce lasting changes in neural activity termed as long-term potentiationlike and long-term depressionlike effects, emphasizing the role of neural plasticity as an agent of symptomatic improvement. Overall, despite the promising findings, most of the methods lead to mixed results, indicating the need to optimize the therapeutic parameters and test their safety and efficiency on largescale randomized controlled studies. Obviously, a better understanding of the pathophysiology of schizophrenia using the approach described in the first review 1 can lead to optimization of brain stimulation techniques for treatment purposes. It should be noted that classical TMS paradigms used to measure neural excitability changes are based on measurements of peripheral motor responses to stimulation over the primary motor cortex. In the case of schizophrenia, direct measurements of neural excitability in the prefrontal cortex would obviously be more relevant to the pathophysiology. However, the common choice in previous studies of an indirect measurement based on motor responses, rather than direct measurements of changes in brain potentials using electroencephalogram, was due to massive artifacts generated by the electromagnetic field interference. As a result, most data about the effects of stimulation on brain plasticity, as indicated in the current In Review articles, are limited to plasticity of the motor cortex. Technological advances of recent years overcame this difficulty. In fact, Daskalakis' group is one of the pioneers in the TMS field and has already managed to demonstrate measures of changes in cortical excitability and inhibition in the dorsolateral prefrontal cortex, which is implicated in schizophrenia. Future research will extend our understanding of the relation between morbidity and neural plasticity in more relevant brain areas.
